IndiaMart
FIEO
Cagrilintide 2.5mg + Semaglutide 5mg (10mg blend) is a dual-acting peptide formulation that combines two powerful compounds — Cagrilintide, an amylin analogue, and Semaglutide, a GLP-1 receptor agonist. Together, they deliver a synergistic effect for research into weight loss, obesity management, and metabolic balance, helping scientists study advanced approaches to appetite regulation and glucose control.
BLUEPILL EXPRESS, a renowned merchant exporter, supplies Cagrilintide + Semaglutide 10mg blends manufactured in GMP-certified facilities located in India and China, according to client sourcing preferences. Every batch is laboratory-tested for purity, potency, and consistency, meeting international peptide research standards and ensuring high-quality global export.
Key Features of Cagrilintide 2.5mg + Semaglutide 5mg (10mg blend):
- Dual peptide formula combining amylin analogue and GLP-1 receptor agonist
- Ideal for research on weight management, metabolic health, and obesity
- Mimics natural hormonal regulation of appetite and glucose metabolism
- Manufactured in India and China under GMP-compliant conditions
- Distributed worldwide by BLUEPILL EXPRESS – merchant exporter of peptides
- Available in bulk quantities, OEM production, and private labeling
- Supplied with COA, MSDS, and export documentation
- Suitable for biomedical, pharmacological, and endocrinological research
BLUEPILL EXPRESS is a trusted merchant exporter of research-grade peptides including Cagrilintide 2.5mg + Semaglutide 5mg, Semaglutide 20mg, BPC-157, TB500, and CJC-1295. With manufacturing facilities in both India and China, the company ensures high production flexibility, cost-effective pricing, and timely global delivery.
By partnering with BLUEPILL EXPRESS, clients gain access to top-quality peptides, GMP-certified manufacturing, and complete export solutions for research and development needs worldwide.
